{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:11:50Z","timestamp":1791079910243,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1136\/ard.2007.073452","type":"journal-article","created":{"date-parts":[[2007,7,21]],"date-time":"2007-07-21T00:34:01Z","timestamp":1184978041000},"page":"168-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement"],"prefix":"10.1016","volume":"67","author":[{"given":"M","family":"Deberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-E","family":"Dubuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Labasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Quettier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bosseloir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-M","family":"Crielaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Henrotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.073452_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","article-title":"Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States","volume":"41","author":"Lawrence","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.073452_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.joca.2006.04.001","article-title":"Classification of osteoarthritis biomarkers: a proposed approach","volume":"14","author":"Bauer","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2007.073452_bib3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ncprheum0132","article-title":"Biochemical markers in osteoarthritis: will they measure up?","volume":"2","author":"Garnero","year":"2006","journal-title":"Nat Clin Pract"},{"key":"10.1136\/ard.2007.073452_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11926-006-0023-5","article-title":"Use of biochemical markers to study and follow patients with osteoarthritis","volume":"8","author":"Garnero","year":"2006","journal-title":"Curr Rheumatol Rep"},{"key":"10.1136\/ard.2007.073452_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.berh.2005.09.001","article-title":"Do biochemical markers have a role in osteoarthritis diagnosis and treatment?","volume":"20","author":"Kraus","year":"2006","journal-title":"Best Practice Res"},{"key":"10.1136\/ard.2007.073452_bib6","first-page":"61","article-title":"Collagen biomarkers for arthritis applications","volume":"2","author":"Birmingham","year":"2006","journal-title":"Biomark Ins"},{"key":"10.1136\/ard.2007.073452_bib7","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1172\/JCI119316","article-title":"Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage","volume":"99","author":"Billinghurst","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2007.073452_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jim.2004.09.005","article-title":"The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases","volume":"294","author":"Poole","year":"2004","journal-title":"J Immunol Meth"},{"key":"10.1136\/ard.2007.073452_bib9","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.joca.2006.04.009","article-title":"Association between concentrations of urinary type II collagen neoepitope (uTIINE) and joint space narrowing in patients with knee osteoarthritis","volume":"14","author":"Hellio Le Graverand","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2007.073452_bib10","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI117156","article-title":"Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay","volume":"93","author":"Hollander","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2007.073452_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.joca.2004.12.002","article-title":"New serum biochemical markers (Coll2-1 and Coll2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis","volume":"13","author":"Deberg","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2007.073452_bib12","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/art.20930","article-title":"Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis","volume":"52","author":"Charni","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.073452_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/mp.52.6.323","article-title":"Differential detection of type II collagen N-terminal and C-terminal denaturation epitopes in degrading cartilage","volume":"52","author":"Croucher","year":"1999","journal-title":"Mol Pathol"},{"key":"10.1136\/ard.2007.073452_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cca.2005.09.020","article-title":"Review: collagen markers in early arthritic diseases","volume":"365","author":"Elsaid","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1136\/ard.2007.073452_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S8756-3282(01)00504-X","article-title":"Collagen type II C-telopeptide fragments as an index of cartilage degradation","volume":"29","author":"Christgau","year":"2001","journal-title":"Bone"},{"key":"10.1136\/ard.2007.073452_bib16","first-page":"543","article-title":"Type II collagen peptides for measuring cartilage degradation","volume":"41","author":"Henrotin","year":"2004","journal-title":"Biorheology"},{"key":"10.1136\/ard.2007.073452_bib17","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.joca.2005.06.014","article-title":"One-year increase of Coll2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression","volume":"13","author":"Deberg","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2007.073452_bib18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s003900050270","article-title":"Neutrophil myeloperoxidase revisited: its role in health and disease","volume":"36","author":"Deby-Dupont","year":"1999","journal-title":"Intensivmed"},{"key":"10.1136\/ard.2007.073452_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pharmthera.2005.06.023","article-title":"Myeloperoxidase and its contributory role in inflammatory vascular disease","volume":"111","author":"Lau","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1136\/ard.2007.073452_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00041433-200308000-00003","article-title":"Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment","volume":"14","author":"Brennan","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"10.1136\/ard.2007.073452_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/abbi.1998.0772","article-title":"Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide","volume":"356","author":"Sampson","year":"1998","journal-title":"Arch Biochem Biophys"},{"key":"10.1136\/ard.2007.073452_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1042\/BJ20040148","article-title":"Hypochlorite and superoxide radicals can act synergistically to induce fragmentation of hyaluronan and chondroitin sulphates","volume":"381","author":"Rees","year":"2004","journal-title":"Biochemical J"},{"key":"10.1136\/ard.2007.073452_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/10715769809065797","article-title":"The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs","volume":"28","author":"Shabani","year":"1998","journal-title":"Free Radical Res"},{"key":"10.1136\/ard.2007.073452_bib24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.073452_bib25","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/clinchem\/44.11.2281","article-title":"Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen","volume":"44","author":"Rosenquist","year":"1998","journal-title":"Clin Chem"},{"key":"10.1136\/ard.2007.073452_bib26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/art.1780310510","article-title":"Serum keratan sulfate levels in osteoarthritis patients","volume":"31","author":"Sweet","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.073452_bib27","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1002\/art.20493","article-title":"Association between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY study","volume":"50","author":"Garnero","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.073452_bib28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/ard.2005.040642","article-title":"Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study","volume":"65","author":"Meulenbelt","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.073452_bib29","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/rheumatology\/32.7.562","article-title":"Production of active oxygen species by isolated human chondrocytes","volume":"32","author":"Henrotin","year":"1993","journal-title":"Brit J Rheumatol"},{"key":"10.1136\/ard.2007.073452_bib30","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4049\/jimmunol.145.2.690","article-title":"Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines","volume":"145","author":"Tiku","year":"1990","journal-title":"J Immunol"},{"key":"10.1136\/ard.2007.073452_bib31","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1002\/art.20581","article-title":"Lectin-like oxidized low-density lipoprotein receptor 1 mediates matrix metalloproteinase 3 synthesis enhanced by oxidized low-density lipoprotein in rheumatoid arthritis cartilage","volume":"50","author":"Kakinuma","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.073452_bib32","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1002\/art.21239","article-title":"The presence of molecular markers of in vivo lipid peroxidation in osteoarthritic cartilage: a pathogenic role in osteoarthritis","volume":"52","author":"Shah","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.073452_bib33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1063-4584(02)00348-5","article-title":"Malondialdehyde oxidation of cartilage collagen by chondrocytes","volume":"11","author":"Tiku","year":"2003","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2007.073452_bib34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10067-003-0761-y","article-title":"Synovial fluid nitric oxide levels in patients with knee osteoarthritis","volume":"22","author":"Karan","year":"2003","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2007.073452_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/jvet.2001.21397","article-title":"Endogenous nitric oxide production in canine osteoarthritis: detection in urine, serum, and synovial fluid specimens","volume":"30","author":"Spreng","year":"2001","journal-title":"Vet Surg"},{"key":"10.1136\/ard.2007.073452_bib36","first-page":"1662","article-title":"Nitrite and nitrotyrosine concentrations in articular cartilage, subchondral bone, and trabecular bone of normal juvenile, normal adult, and osteoarthritic adult equine metacarpophalangeal joints","volume":"33","author":"van der Harst","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.073452_bib37","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/art.10496","article-title":"Detection of nitrotyrosine in aging and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin-1beta and with chondrocyte resistance to insulin-like growth factor 1","volume":"46","author":"Loeser","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.073452_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-5793(94)00722-5","article-title":"Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients","volume":"350","author":"Kaur","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1136\/ard.2007.073452_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/ard.61.1.76","article-title":"Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis","volume":"61","author":"Ersoy","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.073452_bib40","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.51.11.1219","article-title":"Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases","volume":"51","author":"Farrell","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.073452_bib41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/10408360591001886","article-title":"New biochemical insights into the pathogenesis of osteoarthritis and the role of laboratory investigations in clinical assessment","volume":"42","author":"Punzi","year":"2005","journal-title":"Crif Rev Clin Lab Sci"},{"key":"10.1136\/ard.2007.073452_bib42","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.joca.2006.10.010","article-title":"Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis","volume":"15","author":"Pearle","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2007.073452_bib43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/abbi.1995.1303","article-title":"Tyrosine modification by reactive nitrogen species: a closer look","volume":"319","author":"van der Vliet","year":"1995","journal-title":"Arch Biochem Biophys"},{"key":"10.1136\/ard.2007.073452_bib44","first-page":"1595","article-title":"Nitric oxide downregulates interleukin 1beta (IL-1beta) stimulated IL-6, IL-8, and prostaglandin E2 production by human chondrocytes","volume":"25","author":"Henrotin","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.073452_bib45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/bbrc.1993.1637","article-title":"Induction of nitric oxide synthase in human chondrocytes","volume":"193","author":"Palmer","year":"1993","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1136\/ard.2007.073452_bib46","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.4049\/jimmunol.147.11.3915","article-title":"Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide","volume":"147","author":"Stadler","year":"1991","journal-title":"J Immunol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672421904X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672421904X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.073452","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:39:32Z","timestamp":1737250772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672421904X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S000349672421904X"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.073452","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.073452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 2008 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}